Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Revenue | 50.65 | 1.47 | 1.22 | 0.83 |
Total Revenue | 50.65 | 1.47 | 1.22 | 0.83 |
Costof Revenue Total | 50.55 | 1.46 | 1.21 | 0.83 |
Gross Profit | 0.10 | 0.02 | 0.01 | 0.01 |
Selling/ General/ Admin Expenses Total | 2.94 | 2.87 | 3.11 | 3.07 |
Depreciation/ Amortization | 0.83 | 0.00 | 0.00 | 0.00 |
Other Operating Expenses Total | 1.40 | 0.00 | 0.03 | 0.01 |
Total Operating Expense | 55.72 | 4.94 | 4.38 | 3.93 |
Operating Income | -5.08 | -3.47 | -3.16 | -3.10 |
Interest Inc( Exp) Net- Non- Op Total | 11.54 | 430.86 | 570.97 | 264.97 |
Other Net | 42.87 | 0.00 | 0.00 | - |
Net Income Before Taxes | 38.94 | 39.62 | 53.94 | 23.40 |
Provisionfor Income Taxes | 0.33 | 0.40 | -0.67 | -1.05 |
Net Income After Taxes | 38.61 | 39.23 | 54.60 | 24.45 |
Net Income Before Extra Items | 38.61 | 39.23 | 54.60 | 24.45 |
Net Income | 38.61 | 39.23 | 54.60 | 24.45 |
Income Availableto Com Excl Extra Ord | 38.61 | 39.23 | 54.60 | 24.45 |
Income Availableto Com Incl Extra Ord | 38.61 | 39.23 | 54.60 | 24.45 |
Diluted Net Income | 38.61 | 39.23 | 54.60 | 24.45 |
Diluted Weighted Average Shares | 6.96 | 6.95 | 6.95 | 6.95 |
Diluted EPS Excluding Extra Ord Items | 5.55 | 5.64 | 7.85 | 3.52 |
DPS- Common Stock Primary Issue | 5.70 | 6.50 | 5.65 | 3.40 |
Diluted Normalized EPS | 5.55 | 5.64 | 7.85 | 3.52 |
Interest Exp( Inc) Net- Operating Total | - | 6.03 | 0.33 | 0.35 |
Uniphos Enterprises Dividend Uniphos Enterprises Bonus Uniphos Enterprises News Uniphos Enterprises AGM Uniphos Enterprises Rights Uniphos Enterprises Splits Uniphos Enterprises Board Meetings Uniphos Enterprises Key Metrics Uniphos Enterprises Shareholdings Uniphos Enterprises Balance Sheet Uniphos Enterprises Cashflow Uniphos Enterprises Q1 Results Uniphos Enterprises Q2 Results Uniphos Enterprises Q3 Results Uniphos Enterprises Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks